Recent Quotes View Full List My Watchlist Create Watchlist Indicators DJI Nasdaq Composite SPX Gold Crude Oil Hydroworld Market Index Markets Stocks ETFs Tools Overview News Currencies International Treasuries Veracyte Inc (NQ: VCYT ) 32.26 -1.22 (-3.66%) Streaming Delayed Price Updated: 11:36 AM EDT, Oct 9, 2024 Add to My Watchlist Quote Overview Detailed Quote Charting Historical Prices News All News News Headlines Press Releases Research Quarterly Reports Insider Filings Other Filings All News about Veracyte Inc < Previous 1 2 3 4 5 6 7 8 9 10 Next > New Data Presented at ASTRO 2024 Show that Veracyte’s Decipher Prostate Test Predicts Aggressive Prostate Cancer in African American Men October 02, 2024 From Veracyte, Inc. Via Business Wire Tempus AI Stock Clears Technical Benchmark, Hitting 80-Plus RS Rating September 16, 2024 A Relative Strength Rating upgrade for Tempus AI shows improving technical performance. Via Investor's Business Daily Topics Artificial Intelligence Exposures Artificial Intelligence New Data Presented at ESMO 2024 Show that Veracyte’s Decipher Prostate Test Predicts Chemotherapy Benefit in Patients with Metastatic Prostate Cancer September 15, 2024 From Veracyte, Inc. Via Business Wire A Glimpse Into The Expert Outlook On Veracyte Through 4 Analysts May 08, 2024 Via Benzinga Veracyte Appoints Brent Shafer and Tom Miller, Ph.D., to Its Board of Directors September 04, 2024 From Veracyte, Inc. Via Business Wire Veracyte to Participate in the Morgan Stanley 22nd Annual Global Healthcare Conference August 26, 2024 From Veracyte, Inc. Via Business Wire Veracyte Named a Greater Bay Area Top Workplace by the San Francisco Chronicle August 26, 2024 From Veracyte, Inc. Via Business Wire Thermo Fisher Scientific Stock Sees RS Rating Jump To 81 August 13, 2024 Thermo Fisher Scientific stock saw a positive improvement to its Relative Strength (RS) Rating on Tuesday, rising from 77 to 81. Via Investor's Business Daily Lumen Tech & Upstart Are Among Top 7 Mid Cap Gainers Last Week (Aug 4-Aug 10): Are The Others In Your Portfolio? August 11, 2024 Lumen, Upstart, ADMA, Sweetgreen, Veracyte, Clear Secure, and Core Scientific were best performers last week. Did you invest in them? Via Benzinga Diagnostic Tests Maker Veracyte's Q2 Is 'All-Around Very Good Quarter': Analysts Maintain Bullish View August 07, 2024 Veracyte reports Q2 sales of $114.43M, a 27% increase year over year, surpassing the $100.3 million consensus. Testing revenue rose 31% to $107 million, driven by strong performance of Decipher... Via Benzinga Shopify Posts Upbeat Earnings, Joins Axon Enterprise, Aspen Technology, Illumina, Global Payments And Other Big Stocks Moving Higher On Wednesday August 07, 2024 Via Benzinga Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Wednesday August 07, 2024 Pre-market stock movers are a hot topic on Wednesday and we have all of the latest news traders need to know about them this morning! Via InvestorPlace VCYT Stock Earnings: Veracyte Beats EPS, Beats Revenue for Q2 2024 August 06, 2024 VCYT stock results show that Veracyte beat analyst estimates for earnings per share and beat on revenue for the second quarter of 2024. Via InvestorPlace Veracyte Announces Second Quarter 2024 Financial Results August 06, 2024 From Veracyte, Inc. Via Business Wire The 3 Best Personalized Nutrition Stocks to Buy Now July 24, 2024 Explore personalized nutrition stocks capitalizing on AI, machine learning and genetic profiling to provide targeted dietary solutions. Via InvestorPlace Topics Artificial Intelligence Exposures Artificial Intelligence Veracyte to Release Second Quarter 2024 Financial Results on August 6, 2024 July 17, 2024 From Veracyte, Inc. Via Business Wire Trading SMID Biotech Stocks In A Volatile Market July 01, 2024 Trading SMID biotech stocks is difficult no matter what you know. Large cap biopharma with dividends should be the focus for non-traders. Healthcare and smaller caps are lagging within the context of a... Via Talk Markets Cathie Wood-Lead Ark Invest Dumps $7.6M Worth Of Robinhood Shares Amid GameStop Buzz, Bitcoin Choppiness June 10, 2024 On Monday, Cathie Wood-led Ark Invest made a significant move by reducing its holdings in Robinhood Markets Inc (NASDAQ:HOOD). This decision came amidst a period of market fluctuations and followed a... Via Benzinga Veracyte Announces that New Afirma GRID Data Suggest Prognostic Ability of Molecular Testing for Thyroid Tumors June 03, 2024 From Veracyte, Inc. Via Business Wire Veracyte Announces Multiple Afirma GRID Presentations at ENDO 2024, Previewing the Future of Molecular Testing in Thyroid Nodules and Cancer May 22, 2024 From Veracyte, Inc. Via Business Wire Veracyte to Participate in Upcoming Investor Conferences May 15, 2024 From Veracyte, Inc. Via Business Wire VCYT Stock Earnings: Veracyte Beats EPS, Beats Revenue for Q1 2024 May 07, 2024 VCYT stock results show that Veracyte beat analyst estimates for earnings per share and beat on revenue for the first quarter of 2024. Via InvestorPlace Veracyte Announces First Quarter 2024 Financial Results May 07, 2024 From Veracyte, Inc. Via Business Wire 14 Studies Presented at AUA 2024 Show Decipher Tests’ Ability to Help Personalize Care for Prostate and Bladder Cancer Patients and Advance Disease Understanding May 06, 2024 From Veracyte, Inc. Via Business Wire Veracyte to Release First Quarter 2024 Financial Results on May 7, 2024 April 22, 2024 From Veracyte, Inc. Via Business Wire New Study Shows Veracyte’s Decipher Prostate Test is Prognostic for Prostate Cancer Progression Among Patients Undergoing Active Surveillance April 22, 2024 From Veracyte, Inc. Via Business Wire Veracyte Announces that Nine Studies Reinforcing the Value of Decipher Prostate and Decipher Bladder Testing Will Be Presented at AUA 2024 April 16, 2024 From Veracyte, Inc. Via Business Wire Cathie Wood's Ark Invest Dumps $17M In Coinbase Shares As The Exchange Grappled With Disruption Amid Bitcoin Rally February 28, 2024 On Wednesday, Cathie Wood-led Ark Invest made a significant move by selling over $17 million worth of Coinbase Global Inc (NASDAQ:COIN) shares. Via Benzinga Cathie Wood's Ark Invest Sheds $9.3M Worth Of Coinbase Shares Amid Bitcoin Rally — Robinhood Stock Also Sold February 27, 2024 On Tuesday, Cathie Wood-led Ark Invest adjusted its portfolio, making significant trades. Via Benzinga Veracyte’s Decipher Prostate Test Receives Highest Evidence-Level Rating Among Molecular Tests in Updated Prostate Cancer NCCN Guidelines February 27, 2024 From Veracyte, Inc. Via Business Wire < Previous 1 2 3 4 5 6 7 8 9 10 Next > Data & News supplied by www.cloudquote.io Stock quotes supplied by Barchart Quotes delayed at least 20 minutes. By accessing this page, you agree to the following Privacy Policy and Terms and Conditions.